For the Inventor, By the Inventor

Enter inventor name

Boulder, CO, United States of America

Charles A Dinarello

USPTO Granted Patents = 43 (Patent Applications = 32)

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 17)

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 190(Granted Patents)

Location History:

Boston, MA (US) (1984 - 1991)
Suffolk, MA (US) (1999)
Boulder, CO (US) (1999 - 2024)
Denver, CO (US) (2012 - 2024)

Company Filing History:

16 out of 1,382

University of Colorado

Yeda Research and Develpment & Co. Ltd

Ares Trading S.a.

Olatec Therapeutics LLC

Wellesley College

6. 4 out of 702

Tufts University

New England Medical Center Hospitals. Inc.

Konkuk University Industry Cooperation Foundation

Senesco Technologies, Inc.

10. 2 out of 10

11. 2 out of 8,375

Massachusetts Institute of Technology

12. 1 out of 14

New England Medical Center

13. 1 out of 11

Bio-techne Corporation

14. 1 out of 403

Virginia Commonwealth University

15. 1 out of 344

Ben-gurion University of the Negev Research and Development Authority

16. 1 out of 48

Italfarmaco Spa

17. 2 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Cardiovascular Diseases

Alpha-1 Antitrypsin Fusion Polypeptides

Melanoma Treatment

Alzheimer's Disease

Graft Versus Host Disease

Tumor Necrosis Factor-alpha

Interleukin-18 Binding Proteins

Cancer Treatment

Apoptosis Modulation

HIV Infections

Sepsis Treatment

Interleukin-32 Inhibition

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12318361 - Methods for treating cardiovascular diseases (2025-06-03),

2. 12030958 - Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides (2024-07-09),

3. 11857529 - Methods for treating melanoma (2024-01-02),

4. 11576888 - Methods for treating cardiovascular diseases (2023-02-14),

5. 11524985 - IL-37 fusion protein and methods of making and using same (2022-12-13),

6. 11517554 - Method for preventing or treating Alzheimer's disease (2022-12-06),

7. 10723784 - Compositions and methods for preparing a subject for organ or non-organ implantation (2020-07-28),

8. 10548870 - Method for treating multiple sclerosis (2020-02-04),

9. 10478508 - Compositions, methods and uses for alpha-1 antitrypsin fusion molecules (2019-11-19),

10. 10450384 - Compositions of alpha-1 antitrypsin fusion molecules (2019-10-22),

11. 9938353 - Compositions, methods and uses for alpha-1 antitrypsin fusion molecules (2018-04-10),

12. 9895420 - IL-1beta propeptide and IL-1Ra chimera and methods of using the same (2018-02-20),

13. 9884096 - Compositions and methods related to graft versus host disease and treatments thereof (2018-02-06),

14. 9522179 - Compositions and methods for modulating cardiac conditions (2016-12-20),

15. 9486509 - Compositions and methods for preparing a subject for organ or non-organ implantation (2016-11-08),

Title: Charles A. Dinarello - Pioneering Inventor from Boulder, CO

Introduction: Charles A. Dinarello is a renowned inventor based in Boulder, Colorado, known for his groundbreaking contributions to the field of medical research and biotechnology.

Latest Patents: Charles A. Dinarello holds several patents related to novel pharmaceutical compositions for the treatment of inflammatory diseases and autoimmune disorders.

Career Highlights: With a distinguished career spanning several decades, Dinarello has made significant advancements in understanding the role of cytokines in inflammatory responses, leading to the development of innovative therapies.

Collaborations: Throughout his career, Charles A. Dinarello has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the field of immunology and drug development.

Conclusion: Charles A. Dinarello's pioneering work continues to have a profound impact on the medical and scientific communities, shaping the future of healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…